AU4674797A - Phenylalaninol derivatives for the treatment of central nervous system disorders - Google Patents
Phenylalaninol derivatives for the treatment of central nervous system disordersInfo
- Publication number
- AU4674797A AU4674797A AU46747/97A AU4674797A AU4674797A AU 4674797 A AU4674797 A AU 4674797A AU 46747/97 A AU46747/97 A AU 46747/97A AU 4674797 A AU4674797 A AU 4674797A AU 4674797 A AU4674797 A AU 4674797A
- Authority
- AU
- Australia
- Prior art keywords
- treatment
- nervous system
- central nervous
- system disorders
- phenylalaninol derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/30—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by halogen atoms, or by nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2958396P | 1996-10-22 | 1996-10-22 | |
| US60029583 | 1996-10-22 | ||
| PCT/US1997/018683 WO1998017636A1 (en) | 1996-10-22 | 1997-10-20 | Phenylalaninol derivatives for the treatment of central nervous system disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU4674797A true AU4674797A (en) | 1998-05-15 |
Family
ID=21849797
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU46747/97A Abandoned AU4674797A (en) | 1996-10-22 | 1997-10-20 | Phenylalaninol derivatives for the treatment of central nervous system disorders |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU4674797A (en) |
| WO (1) | WO1998017636A1 (en) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2161594B1 (en) * | 1998-12-17 | 2003-04-01 | Servier Lab | NEW DERIVATIVES OF HYDRAZIDE, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. |
| WO2001046152A1 (en) * | 1999-12-21 | 2001-06-28 | Monsanto Technology Llc | Herbicidal diacyl derivatives of propylene diamine |
| JP5024635B2 (en) | 2005-06-08 | 2012-09-12 | エスケー バイオファーマスティカルズ カンパニー リミテッド | Treatment of sleep-wake disorder |
| KR20120098578A (en) | 2009-06-22 | 2012-09-05 | 에스케이바이오팜 주식회사 | Methods for treating or preventing fatigue |
| US8232315B2 (en) * | 2009-06-26 | 2012-07-31 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating drug addiction and improving addiction-related behavior |
| KR101783632B1 (en) | 2009-11-06 | 2017-10-10 | 에스케이바이오팜 주식회사 | Methods for treating Attention-Deficit/Hyperactivity Disorder |
| WO2011055944A2 (en) | 2009-11-06 | 2011-05-12 | Sk Holdings Co., Ltd. | Methods for treating fibromyalgia syndrome |
| US9610274B2 (en) | 2010-06-30 | 2017-04-04 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating bipolar disorder |
| JP6530741B2 (en) | 2013-03-13 | 2019-06-12 | エアリアル，バイオファーマ，エルエルシー | Treatment of cataplexy |
| KR20160030955A (en) * | 2013-07-12 | 2016-03-21 | 에스케이바이오팜 주식회사 | Promotion of smoking cessation |
| PL3021838T3 (en) | 2013-07-18 | 2021-03-08 | Jazz Pharmaceuticals Ireland Limited | Treatment for obesity |
| WO2017007695A1 (en) | 2015-07-09 | 2017-01-12 | The Regents Of The University Of California | Mu opioid receptor modulators |
| US10195151B2 (en) | 2016-09-06 | 2019-02-05 | Jazz Pharmaceuticals International Iii Limited | Formulations of (R)-2-amino-3-phenylpropyl carbamate |
| BR112019025286A2 (en) | 2017-06-02 | 2020-06-23 | Jazz Pharmaceuticals Ireland Limited | METHODS AND COMPOSITIONS FOR TREATING EXCESSIVE SLEEPING |
| AU2018312328B2 (en) * | 2017-07-31 | 2022-12-15 | Jazz Pharmaceuticals Ireland Limited | Carbamoyl phenylalaninol analogs and uses thereof |
| JP7402857B2 (en) | 2018-04-04 | 2023-12-21 | エピオダイン，インク． | Opioid receptor modulators and related products and methods |
| US10940133B1 (en) | 2020-03-19 | 2021-03-09 | Jazz Pharmaceuticals Ireland Limited | Methods of providing solriamfetol therapy to subjects with impaired renal function |
| TW202304869A (en) | 2021-04-05 | 2023-02-01 | 美商艾碧奧戴股份有限公司 | Opioid receptor modulators |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5106873A (en) * | 1990-06-26 | 1992-04-21 | Warner-Lambert Company | ACAT inhibitors |
| GB9027055D0 (en) * | 1990-12-13 | 1991-02-06 | Sandoz Ltd | Organic compounds |
| FR2690917B1 (en) * | 1992-05-05 | 1994-06-17 | Jouveinal Inst Rech | AMINOESTERS, THEIR PREPARATION PROCESS AND THEIR APPLICATION IN THERAPEUTICS. |
| US6403577B1 (en) * | 1993-11-17 | 2002-06-11 | Eli Lilly And Company | Hexamethyleneiminyl tachykinin receptor antagonists |
| JPH07278080A (en) * | 1994-04-12 | 1995-10-24 | Sagami Chem Res Center | Alanylalaninol derivative |
-
1997
- 1997-10-20 AU AU46747/97A patent/AU4674797A/en not_active Abandoned
- 1997-10-20 WO PCT/US1997/018683 patent/WO1998017636A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO1998017636A1 (en) | 1998-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2736097A (en) | Method for preparation of compounds useful for prevention and treatment of central nervous system disorders | |
| AU4880197A (en) | Method for treatment of dermatological disorders | |
| AUPM864894A0 (en) | Treatment of bowel-dependent neurological disorders | |
| AU4674797A (en) | Phenylalaninol derivatives for the treatment of central nervous system disorders | |
| AU3056297A (en) | Techniques of treating neurodegenerative disorders by brain infusion | |
| GB2305605B (en) | Pipecolic acid derivatives for the treatment of neurological disorders | |
| AU2423697A (en) | System for treating patients with anxiety disorders | |
| IL121170A0 (en) | Compositions for the treatment of dermatological disorders | |
| AU6112896A (en) | Tyrphostin-like compounds for the treatment of cell prolifer ative disorders or cell differentiation disorders | |
| AU3548795A (en) | Benzopyranopyrazolyl derivatives for the treatment of inflammation | |
| AU8769098A (en) | System for treating patients with anxiety disorders | |
| AU5981098A (en) | Therapeutic gestagens for the treatment of premenstrual dysphoric disorder | |
| AU4078997A (en) | Cholinesterase inhibitors for treatment of parkinson's disease | |
| AU6222096A (en) | Phenoxy piperazine derivatives for treating disorders of the dopamine system | |
| AU6910600A (en) | Methods for the treatment of mental disorders | |
| AU4372597A (en) | Method for the treatment of neurological or neuropsychiatric disorders | |
| AU2508597A (en) | Drug for the treatment of tumours | |
| AU2384500A (en) | Compounds, methods of screening and methods of treatment for central and peripheral nervous system disorders | |
| AU2058697A (en) | Treatment of sleep disorders | |
| AU2325999A (en) | Methods of neuroendocrine regulation of affective disorders | |
| AU1578295A (en) | Use of arylcyclobutylalkylamines for the treatment of seizures and neurological disorders | |
| AU2555397A (en) | Macrophage stimulating protein for the treatment of gastrointestinal disorders | |
| AU9763098A (en) | Method for the treatment of disorders associated with apoptosis using n-heterocyclic glyoxylamide compounds | |
| AU6485496A (en) | Compounds and methods for treatment of egf receptor associated cancers and purification of the egf receptor | |
| AU3596797A (en) | Methods for the treatment of apolipoprotein e related diseases |